Guidelines for the clinical evaluation of lipid-altering agents in adults and children
Contributors: United States. Food and Drug Administration. Bureau of Drugs
Series: FDA Bureau of Drugs clinical guidelines; HHS publication -- no. (FDA) 80-3103; HHS publication -- (FDA) 80-3103
Publisher: Division of Metabolism and Endocrine Drug Products, Bureau of Drugs, Food and Drug Administration; For sale by the Superintendent of Documents, U.S. Government Printing Office
Published: 1980
Place of publication: Rockville, Maryland; Washington D.C
Language: eng
Number of pages: 10
Subjects: Drug Evaluation; Lipids; Blood; Hyperlipoproteinemias; Drug therapy; Hypolipidemic Agents; Standards; Drugs; Testing; Blood lipids; Hyperlipoproteinemia
Notes: Developed by the FDA Bureau of Drugs with the assistance of various advisory committees.

"July 1980."